Abstract
The oncoprotein v-erbA is a mutated form of TRα1 that is unable to bind thyroid hormone (T3). V-erbA homodimerizes or heterodimerizes with retinoid X receptor (RXR) on core motifs arranged as direct, everted, or inverted repeats (DRs, ERs, or IRs). We created a series of v-erbA mutants in order to obtain a better understanding of the role of v-erbA homodimers versus v-erbA-RXR heterodimers in the dominant negative activity of v-erbA on ERs (the most potent v-erbA response elements). We found that one of these mutants, v-erbA mutant E325A, is able to homodimerize but unable to heterodimerize with RXR on ERs. Our data also suggest that v-erbA homodimers interact preferentially with the corepressor NCoR over SMRT and that the interaction with corepressors is stronger with v-erbA homodimers over v-erbA-RXR heterodimers. Furthermore, functional studies showed that v-erbA homodimers rather than v-erbA-RXR heterodimers mediate the dominant negative activity of v-erbA on ERs.
Similar content being viewed by others
References
Evans RM (1988) Science 240, 889–895.
Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H & Vennstrom B (1986) Nature 324: 635–640.
Sharif M & Privalsky ML (1991) Cell 66: 885–893.
Damm K, Thompson CC & Evans RM (1989) Nature 339: 593–597.
Horlein AJ, Naar A, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK & Rosenfeld MG (1995) Nature 377: 397–404.
Chen DJ & Evans RM (1995) Nature 377: 454–457.
Robyr D, Wolffe AP & Wahli W (2000) Mol. Endocrinol. 14: 329–347.
Shen Q & Subauste JS (2000) J. Biol. Chem. 275: 41018–41027.
Subauste JS & Koenig RJ (1998) Mol. Endocrinol. 12: 1380–1392.
Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Garnier JM, Mader S & Chambon P (1992) Cell 68, 377–395.
Hollenberg AN, Monden T, Madura JP, Lee K & Wondisford FE (1996) J. Biol. Chem. 271: 28516–28520.
Chen JD, Umesono K & Evans RM (1996) Proc. Natl. Acad. Sci. USA 93: 7567–7571.
Prost E, Koenig RJ, Moore DD, Larsen PR & Whalen RG (1988) Nucl. Acids Res. 16: 6248.
Subauste JS & Koenig RJ (1995) J. Biol. Chem. 270: 7957–7962.
Prost E & Moore DD (1986) Gene 45: 107–111.
Koenig RJ, Warne RL, Brent GA, Harney JW, Larsen PR & Moore DD (1988) Proc. Natl. Acad. Sci. USA 85: 5031–5035.
Thompson CC & Evans RM (1989) Proc. Natl. Acad. Sci. USA 86: 3494–3498.
Perlmann T, Umesono K, Rangarajan P, Forman BM & Evans RM (1996) Mol. Endocrinol. 10: 958–966.
Zubkova I & Subauste JS (2003) Mol. Cell. Endocrinol. 199: 61–72.
Zechel C, Shen XQ, Chen JY, Chen Z, Chambon P & Gronemeyer H (1994) EMBO J. 13: 1425–1433.
Mader S, Chen JY, Chen Z, White J, Chambon P & Gronemeyer H (1993) EMBO J. 12: 5029–5041.
Umesono K, Murakami KK, Thompson CC & Evans RM (1991) Cell 65: 1255–1266.
Mangelsdorf DJ, Umesono K, Kliewer SA, Borgmeyer U, Ong ES & Evans RM (1991) 66: 555–561.
Mangelsdorf DJ & Evans RM (1995) Cell 83: 841–850.
Cohen RN, Wondisford FE & Hollenberg AN (1998) Mol. Endocrinol. 12: 1567–1581.
Barlow C, Meister B, Lardelli M, Lendahl U & Vennstrom B (1994) EMBO J. 13: 4241–4250.
Feng X, Jiang Y, Metzer P & Yen PM (2000) Mol. Endocrinol. 14: 947–955.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zubkova, I., Subauste, J.S. V-erba homodimers mediate the potent dominant negative activity of v-erba on everted repeats. Mol Biol Rep 31, 131–137 (2004). https://doi.org/10.1023/B:MOLE.0000031412.25988.30
Issue Date:
DOI: https://doi.org/10.1023/B:MOLE.0000031412.25988.30